Related Experiment Videos

[Orbital lymphoblastic lymphoma in 7 years old child]

Joanna Siwiec-Prościńska1, Anna Gotz-Wieckowska, Jarosław Kociecki

  • 1Katedra i Klinika Okulistyki Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. joannaproscinska@interia.pl

Klinika Oczna
|January 26, 2013
PubMed

Insights

This study reports a rare case of lymphoblastic lymphoma in a 7-year-old boy. Early diagnosis through biopsy is crucial for effective chemotherapy and treatment of this orbital tumor.

Area of Science:

  • Oncology
  • Ophthalmology
  • Pediatric Hematology-Oncology

Background:

  • Orbital tumors are rare in children, requiring prompt diagnosis and management.
  • Lymphoblastic lymphoma is an aggressive form of non-Hodgkin lymphoma.

Observation:

  • A 7-year-old boy presented with rapidly progressing unilateral orbital edema and redness.
  • Physical examination revealed temporal swelling and narrowing of the palpebral fissure.

Findings:

  • Imaging (ultrasound, MRI) and biopsy confirmed lymphoblastic lymphoma originating from B cells.
  • This represents a very rare type of lymphoma for this age and orbital location.

Implications:

  • Histopathological and immunohistochemical evaluation is essential for accurate lymphoma diagnosis.
  • Tailored chemotherapy based on specific lymphoma subtype is critical for successful treatment outcomes.

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...